Stick To The Plan – But Be Ready To Change
An Interview With ‘Rising Leader’ Christophe Bancel, CEO Of TISSIUM
Executive Summary
Know your strengths, surround yourself with experts and ensure your solution “does what it says on the tin.” These are among the guiding principles of Christophe Bancel, co-founder of France’s biopolymer innovator TISSIUM, a health care start-up on the cusp of commercialization.
You may also be interested in...
Novel Tissue Recon Surgery Without The Trauma
With a fairly unlimited range of potential tissue repair applications, polymer device innovator Tissium can pursue a “relatively open” business model, CEO Christophe Bancel told In Vivo.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.